JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: TAS-103 dihydrochloride (also known as BMS-247615) is a potent and dual inhibitor of DNA topoisomerase I/II. It is a quinoline derivative that displays antitumor activity in murine and human tumor models. TAS-103 is active on CCRF-CEM cells with an IC50 value of 5 nM. TAS-103 at 0.1 uM significantly increases levels of topo IIalpha FITC immunofluorescence in individual CCRF-CEM cells. TAS-103 inhibits the viability of HeLa cells, with an IC50 of 40 nM. TAS-103 at 10 uM disrupts signal recognition particle (SRP) complex formation, and induces destabilization of SRP14 and SRP19 and its eventual degradation. Although TAS-103 has been reported to be a potent topoisomerase II poison. However, other studies have indicated that cellular susceptibility to TAS-103 is not correlated with topoisomerase II expression.
References: Biochem Pharmacol. 2000 Sep 15; 60(6):817-21; Mol Pharmacol. 2008 Mar; 73(3):987-94. Epub 2007 Dec 18.
Related CAS#: 174634-09-4 (diHCl salt); 174634-08-3 (free base)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!